Intercure Ltd. (INCR) stock
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.63−0.16 (-4.22%)
Close on Nov 16, 2026Market cap $198.49MP/E –Yield –
Intercure cash
Cash and short-term investments held at the end of each period.
Intercure's cash was 46.47M ILS at Dec 31, 2025. For fiscal 2025 it was 46.47M ILS, down 40.7% from the year before. The highest annual figure on record is 232.59M ILS in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.47M ILS | -40.7% |
| FY2024 | Dec 31, 2024 | 78.32M ILS | -22.6% |
| FY2023 | Dec 31, 2023 | 101.14M ILS | -56.5% |
| FY2022 | Dec 31, 2022 | 232.59M ILS | +18.5% |
| FY2021 | Dec 31, 2021 | 196.22M ILS | +417.9% |
| FY2020 | Dec 31, 2020 | 37.89M ILS | +38.6% |
| FY2019 | Dec 31, 2019 | 27.34M ILS | +700.3% |
| FY2018 | Dec 31, 2018 | 3.42M ILS | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 46.47M ILS | -76.3% |
| Q4 FY2024 | Dec 31, 2024 | 78.32M ILS | +106.7% |
| Q4 FY2023 | Dec 31, 2023 | 101.14M ILS | +270.0% |
| Q4 FY2022 | Dec 31, 2022 | 232.59M ILS | +6708.8% |
| Q4 FY2021 | Dec 31, 2021 | 196.22M ILS | – |
| Q4 FY2020 | Dec 31, 2020 | 37.89M ILS | – |
| Q4 FY2019 | Dec 31, 2019 | 27.34M ILS | – |
| Q4 FY2018 | Dec 31, 2018 | 3.42M ILS | – |
See a number that looks wrong?